<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000630914"><TermName>HMR 1275</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called alvocidib and flavopiridol.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>HMR 1275</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Impide que las células se multipliquen y puede destruir células cancerosas. Es un tipo de inhibidor de la cinasa dependiente de ciclinas (CDK). También se llama alvocidib y flavopiridol.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-12</DateFirstPublished><DateLastModified>2009-02-12</DateLastModified></GlossaryTerm>
